Distribution of β-Lactamase Genes Among Carbapenem-Resistant Klebsiella pneumoniae Strains Isolated From Patients in Turkey
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The emergence of carbapenem-resistant Klebsiella pneumoniae poses a serious problem to antibiotic management. We investigated the β-lactamases in a group of carbapenem-resistant K. pneumoniae clinical isolates from Turkey. Methods: Thirty-seven strains of K. pneumoniae isolated from various clinical specimens were analyzed by antimicrobial susceptibility testing, PCR for the detection of β-lactamase genes, DNA sequencing, and repetitive extragenic palindronic (REP)- PCR analysis. Results: All 37 isolates were resistant to ampicillin, ampicillin/sulbactam, piperacillin, piperacillin/tazobactam, ceftazidime, cefoperazone/sulbactam, cefepime, imipenem, and meropenem. The lowest resistance rates were observed for colistin (2.7%), tigecycline (11%), and amikacin (19%). According to PCR and sequencing results, 98% (36/37) of strains carried at least one carbapenemase gene, with 32 (86%) carrying OXA-48 and 7 (19%) carrying NDM-1. No other carbapenemase genes were identified. All strains carried a CTX-M-2-like β-lactamase, and some carried SHV- (97%), TEM- (9%), and CTX-M-1-like (62%) β-lactamases. Sequence analysis of blaTEM genes identified a blaTEM-166 with an amino acid change at position 53 (Arg53Gly) from blaTEM-1b, the first report of a mutation in this region. REP-PCR analysis revealed that there were seven different clonal groups, and temporo-spatial links were identified within these groups. Conclusions: Combinations of β-lactamases were found in all strains, with the most common being OXA-48, SHV, TEM, and CTX-M-type (76% of strains). We have reported, for the first time, a high prevalence of the NDM-1 (19%) carbapenemase in carbapenem-resistant K. pneumoniae from Turkey. These enzymes often co-exist with other β-lactamases, such as TEM, SHV, and CTX-M β-lactamases.
Abstract
Background: The emergence of carbapenem-resistant Klebsiella pneumoniae poses a serious problem to antibiotic management. We investigated the β-lactamases in a group of carbapenem-resistant K. pneumoniae clinical isolates from Turkey. Methods: Thirty-seven strains of K. pneumoniae isolated from various clinical specimens were analyzed by antimicrobial susceptibility testing, PCR for the detection of β-lactamase genes, DNA sequencing, and repetitive extragenic palindronic (REP)- PCR analysis. Results: All 37 isolates were resistant to ampicillin, ampicillin/sulbactam, piperacillin, piperacillin/tazobactam, ceftazidime, cefoperazone/sulbactam, cefepime, imipenem, and meropenem. The lowest resistance rates were observed for colistin (2.7%), tigecycline (11%), and amikacin (19%). According to PCR and sequencing results, 98% (36/37) of strains carried at least one carbapenemase gene, with 32 (86%) carrying OXA-48 and 7 (19%) carrying NDM-1. No other carbapenemase genes were identified. All strains carried a CTX-M-2-like β-lactamase, and some carried SHV- (97%), TEM- (9%), and CTX-M-1-like (62%) β-lactamases. Sequence analysis of blaTEM genes identified a blaTEM-166 with an amino acid change at position 53 (Arg53Gly) from blaTEM-1b, the first report of a mutation in this region. REP-PCR analysis revealed that there were seven different clonal groups, and temporo-spatial links were identified within these groups. Conclusions: Combinations of β-lactamases were found in all strains, with the most common being OXA-48, SHV, TEM, and CTX-M-type (76% of strains). We have reported, for the first time, a high prevalence of the NDM-1 (19%) carbapenemase in carbapenem-resistant K. pneumoniae from Turkey. These enzymes often co-exist with other β-lactamases, such as TEM, SHV, and CTX-M β-lactamases.
참고문헌 (30)
- Pitout JD, "Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae", F1000 Med Rep, 1, pp.84~ (2009)
- Jadhav S, "Increasıng incidence of multidrug resistance Klebsiella pneumoniae infections in hospital and community settings", Int J Microbiol Res, 4, pp.253~257 (2012)
- Bradford PA, "Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein", Antimicrob Agents Chemother, 4, pp.563~569 (1997)
- Kaczmarek FM, "High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35", 36 insertional inactivation, and down-regulation of the phosphate transport porin phoE, 2006, pp.50, 3396~3406
- Nordmann P, "Carbapenem resistance in Enterobacteriaceae: here is the storm!", Trends Mol Med, 18, pp.263~272 (2012)
- Giani T, "Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011", Euro Surveill, 18, pp.pii:20489~ (2013)
- Poirel L, "Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae", Antimicrob Agents Chemother, 48, pp.15~22 (2004)
- Aktaş Z, "Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumonia in Istanbul, Turkey", Chemotherapy, 54, pp.101~106 (2008)
- Carrër A, "Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumonia isolates in Istanbul, Turkey", Antimicrob Agents Chemother, 52, pp.2950~2954 (2008)
- Gülmez D, "Carbapenem-resistant Escherichia coli and Klebsiella pneumonia isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss", Int J Antimicrob Agents, 31, pp.523~526 (2008)
- Poirel L, "NDM-1- producing Klebsiella pneumoniae now in Turkey", Antimicrob Agents Chemother, 56, pp.2784~2785 (2012)
- Copur Cicek A, "Determination of a novel integron-located variant (blaOXA-320) of Class D β-lactamase in Proteus mirabilis", J Basic Microbiol, 54, pp.1030~1035 (2014)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. M100-S23", Clinical and Laboratory Standards Institute, ~ (2013)
- Altschul SF, "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res, 25, pp.3389~3402 (1997)
- Copur Cicek A, "OXA- and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital", Clin Microbiol Infect, 20, pp.410~415 (2014)
- Copur Cicek A, "Nationwidestudy of Escherichia coli producing extended-spectrum β-lactamases TEM, SHV and CTX-M in Turkey", J Antibiot, 66, pp.647~650 (2013)
- Andriamanantena TS, "Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar", Ann Clin Microbiol Antimicrob, 9, pp.17~ (2010)
- Podschun R, "Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors", Clin Microbiol Rev, 11, pp.589~603 (1998)
- Poirel L, "Carbapenemases: molecular diversity and clinical consequences", Future Microbiol, 2, pp.501~512 (2007)
- Yong D, "Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India", Antimicrob Agents Chemother, 53, pp.5046~5054 (2009)
- Johnson AP, "Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance", J Med Microbiol, 62, pp.499~513 (2013)
- Seija V, "Sepsis caused by New Delhi metallo-β-lactamase (blaNDM-1) and qnrD-producing Morganella morganii, treated successfully with fosfomycin and meropenem: case report and literature review", Int J Infect Dis, 30, pp.20~26 (2015)
- Nordmann P, "The emerging NDM carbapenemases", Trends Microbiol, 19, pp.588~595 (2011)
- Kim SY, "Characteristics of community-onset NDM-1-producing Klebsiella pneumonia isolates", J Med Microbiol, 63, pp.86~89 (2014)
- Rasheed JK, "New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States", Emerg Infect Dis, 19, pp.870~878 (2013)
- Evans B, "OXA β-lactamases", Clin Microbiol Rev, 27, pp.241~263 (2014)
- Alp E, "Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey", J Hosp Infect, 84, pp.178~180 (2013)
- Pitout JD, "Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community", J Antimicrob Chemother, 56, pp.52~59 (2005)
- Gür D, "Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study", Mikrobiyol Bul, 42, pp.537~544 (2008)
- Onnberg A, "Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden", APMIS, 119, pp.287~295 (2011)
